BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22294084)

  • 21. Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.
    Reindl W; Gräber M; Strebhardt K; Berg T
    Anal Biochem; 2009 Dec; 395(2):189-94. PubMed ID: 19716361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C.
    Huang C; Li J; Ke Q; Leonard SS; Jiang BH; Zhong XS; Costa M; Castranova V; Shi X
    Cancer Res; 2002 Oct; 62(20):5689-97. PubMed ID: 12384526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase.
    Kuemmerle JF
    Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G411-22. PubMed ID: 12444011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation, regulation, and inhibition of DYRK1A.
    Becker W; Sippl W
    FEBS J; 2011 Jan; 278(2):246-56. PubMed ID: 21126318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural modes of stabilization of permissive phosphorylation sites in protein kinases: distinct strategies in Ser/Thr and Tyr kinases.
    Krupa A; Preethi G; Srinivasan N
    J Mol Biol; 2004 Jun; 339(5):1025-39. PubMed ID: 15178245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein tyrosine kinase activity assays.
    Hawes BE; van Biesen T
    Curr Protoc Pharmacol; 2001 May; Chapter 3():Unit3.5. PubMed ID: 21965067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide selectivity of antibiotic kinases.
    Shakya T; Wright GD
    Antimicrob Agents Chemother; 2010 May; 54(5):1909-13. PubMed ID: 20231391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
    Reindl W; Strebhardt K; Berg T
    Anal Biochem; 2008 Dec; 383(2):205-9. PubMed ID: 18793607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fluorescence anisotropy-based Myt1 kinase binding assay.
    Rohe A; Henze C; Erdmann F; Sippl W; Schmidt M
    Assay Drug Dev Technol; 2014 Mar; 12(2):136-44. PubMed ID: 24229357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzymatic characteristics of a Ser/Thr protein kinase, SpkA, from Myxococcus xanthus.
    Kimura Y; Kakemizu A; Matsubara Y; Takegawa K
    J Biosci Bioeng; 2009 Jan; 107(1):10-5. PubMed ID: 19147102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of eukaryotic-like protein kinase activity of DspA from Myxococcus xanthus by autophosphorylation.
    Okamoto R; Takegawa K; Kimura Y
    J Biochem; 2014 Feb; 155(2):99-106. PubMed ID: 24194533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA-approved small-molecule kinase inhibitors.
    Wu P; Nielsen TE; Clausen MH
    Trends Pharmacol Sci; 2015 Jul; 36(7):422-39. PubMed ID: 25975227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel quantitative kinase assay using bacterial surface display and flow cytometry.
    Henriques ST; Thorstholm L; Huang YH; Getz JA; Daugherty PS; Craik DJ
    PLoS One; 2013; 8(11):e80474. PubMed ID: 24260399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening kinase inhibitors with a microarray-based fluorescent and resonance light scattering assay.
    Li T; Liu D; Wang Z
    Anal Chem; 2010 Apr; 82(7):3067-72. PubMed ID: 20201592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase.
    Rohe A; Erdmann F; Bäßler C; Wichapong K; Sippl W; Schmidt M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1219-23. PubMed ID: 22189141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure/function studies of Ser/Thr and Tyr protein phosphorylation in Mycobacterium tuberculosis.
    Greenstein AE; Grundner C; Echols N; Gay LM; Lombana TN; Miecskowski CA; Pullen KE; Sung PY; Alber T
    J Mol Microbiol Biotechnol; 2005; 9(3-4):167-81. PubMed ID: 16415590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
    Rudrabhatla P; Rajasekharan R
    Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence polarization competition immunoassay for tyrosine kinases.
    Seethala R
    Methods; 2000 Sep; 22(1):61-70. PubMed ID: 11020319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent cross-linking of kinases with their corresponding peptide substrates.
    Statsuk AV; Shokat KM
    Methods Mol Biol; 2012; 795():179-90. PubMed ID: 21960223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells.
    Mullapudi SR; Ali-Osman F; Shou J; Srivenugopal KS
    Biochem J; 2000 Oct; 351 Pt 2(Pt 2):393-402. PubMed ID: 11023825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.